SEC Form 4 · accession 0000914190-17-000163
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A. Koehn
Officer — SVP Manufacturing & Operations
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 31, 2017 | M | 12,940 | $7.90 | A | 96,929 | D | |
| Common StockF1 | May 31, 2017 | M | 7,060 | $12.15 | A | 103,989 | D | |
| Common StockF2,F1 | May 31, 2017 | S | 20,000 | $29.983 | D | 83,989 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $7.90 | May 31, 2017 | M | 12,940 | D | — | Oct 8, 2017 | Common Stock | 12,940 | 0 | D |
| Stock Option (right to buy)F3 | $12.15 | May 31, 2017 | M | 7,060 | D | — | Dec 11, 2017 | Common Stock | 7,060 | 17,060 | D |
| Stock Option (right to buy)F3 | $8.75 | holding | — | — | — | — | Mar 1, 2019 | Common Stock | 8,087 | 8,087 | D |
Explanation of responses
- F1Includes 602 shares acquired under Cardiovascular Systems, Inc.'s stock purchase plan on December 31, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.96 to $30.01 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3Fully exercisable.